Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Revenue (TTM): 287.61M for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 287.61M |
| June 30, 2023 | 189.56M |
| March 31, 2023 | 120.57M |
| December 31, 2022 | 108.78M |
| September 30, 2022 | 95.61M |
| June 30, 2022 | 89.44M |
| March 31, 2022 | 92.23M |
| December 31, 2021 | 69.86M |
| September 30, 2021 | 127.66M |
| June 30, 2021 | 136.64M |
| March 31, 2021 | 134.72M |
| December 31, 2020 | 132.30M |
| September 30, 2020 | 91.36M |
| June 30, 2020 | 86.46M |
| March 31, 2020 | 86.97M |
| December 31, 2019 | 82.27M |
| September 30, 2019 | 50.82M |
| June 30, 2019 | 48.47M |
| March 31, 2019 | 42.22M |
| December 31, 2018 | 53.45M |
| September 30, 2018 | 79.48M |
| June 30, 2018 | 77.03M |
| March 31, 2018 | 106.76M |
| December 31, 2017 | 115.45M |
| September 30, 2017 | 83.66M |
| Date | Value |
|---|---|
| June 30, 2017 | 82.59M |
| March 31, 2017 | 63.28M |
| September 30, 2016 | 52.81M |
| June 30, 2016 | 60.00M |
| March 31, 2016 | 65.20M |
| December 31, 2015 | 56.92M |
| September 30, 2015 | 87.19M |
| June 30, 2015 | 85.54M |
| March 31, 2015 | 78.67M |
| December 31, 2014 | 74.12M |
| September 30, 2014 | 55.88M |
| June 30, 2014 | 59.90M |
| March 31, 2014 | 57.98M |
| December 31, 2013 | 76.11M |
| September 30, 2013 | 48.66M |
| June 30, 2013 | 35.54M |
| March 31, 2013 | 34.66M |
| December 31, 2012 | 12.91M |
| September 30, 2012 | 17.91M |
| June 30, 2012 | 16.36M |
| March 31, 2012 | 19.91M |
| December 31, 2011 | 21.87M |
| September 30, 2011 | 18.43M |
| June 30, 2011 | 19.30M |
| March 31, 2011 | 17.22M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
48.47M
Minimum
Jun 2019
287.61M
Maximum
Sep 2023
112.85M
Average
93.92M
Median
Revenue (TTM) Benchmarks
| AbbVie Inc | 54.32B |
| Pfizer Inc | 58.50B |
| Johnson & Johnson | 89.66B |
| Merck & Co Inc | 61.40B |
| Cerevel Therapeutics Holdings Inc | -- |